{
    "nctId": "NCT02635737",
    "briefTitle": "Magnetic Seed Localisation of Breast Cancers",
    "officialTitle": "Safety and Feasibility Study of Magnetic Seed Markers to Localise Breast Cancers for Surgical Excision",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 29,
    "primaryOutcomeMeasure": "Migration of Sentimark Device",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant is willing and able to give informed consent for participation in the study;\n* Female, aged 18 years or above;\n* Diagnosed with breast cancer (invasive or dcis);\n* Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study;\n* Undergoing mastectomy breast surgery.\n\nExclusion Criteria:\n\n* Patients with a Pacemaker or implanted device;\n* Patients requiring an MRI scan prior to surgery;\n* Patients with known coagulopathy or receiving anticoagulant medication including warfarin, heparin, clopidogrel or rivaroxaban;\n* Patients receiving Neoadjuvant chemotherapy;\n* Patients who are pregnant or lactating;\n* Patients scheduled for immediate breast reconstruction;\n* Patients who have received Sienna (iron oxide) injection in the previous six months;\n* Patients with an existing breast haematoma close to the target lesion.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}